http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2020, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 30 Nov 2020 16:08:11 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html for the full story. http://www.streetinsider.com/Corporate+News/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html Mon, 30 Nov 2020 16:08:11 -0500 RTRX http://www.streetinsider.com/FDA/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html for the full story. http://www.streetinsider.com/FDA/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html Mon, 30 Nov 2020 16:08:11 -0500 RTRX http://www.streetinsider.com/Management+Comments/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html for the full story. http://www.streetinsider.com/Management+Comments/Travere+Therapeutics+%28RTRX%29+Reports+Complete+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662845.html Mon, 30 Nov 2020 16:08:11 -0500 RTRX http://www.streetinsider.com/Press+Releases/Travere+Therapeutics+Announces+Completion+of+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662788.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Travere+Therapeutics+Announces+Completion+of+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662788.html for the full story. http://www.streetinsider.com/Press+Releases/Travere+Therapeutics+Announces+Completion+of+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662788.html Mon, 30 Nov 2020 16:05:00 -0500 RTRX http://www.streetinsider.com/Globe+Newswire/Travere+Therapeutics+Announces+Completion+of+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662788.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Travere+Therapeutics+Announces+Completion+of+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662788.html for the full story. http://www.streetinsider.com/Globe+Newswire/Travere+Therapeutics+Announces+Completion+of+Patient+Enrollment+in+Pivotal+Phase+3+DUPLEX+Study+of+Sparsentan+in+Focal+Segmental+Glomerulosclerosis/17662788.html Mon, 30 Nov 2020 16:05:00 -0500 RTRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Travere+Therapeutics%2C+++++For%3A+Nov+12/17622142.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Travere+Therapeutics%2C+++++For%3A+Nov+12/17622142.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Travere+Therapeutics%2C+++++For%3A+Nov+12/17622142.html Wed, 18 Nov 2020 17:18:00 -0500 RTRX http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Travere+Therapeutics%2C+++++For%3A+Nov+12/17622115.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Travere+Therapeutics%2C+++++For%3A+Nov+12/17622115.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-KA++++++Travere+Therapeutics%2C+++++For%3A+Nov+12/17622115.html Wed, 18 Nov 2020 17:16:00 -0500 RTRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+ROTE+WILLIAM+E./17616955.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+ROTE+WILLIAM+E./17616955.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+ROTE+WILLIAM+E./17616955.html Tue, 17 Nov 2020 21:00:00 -0500 RTRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+Clague+Laura/17616953.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+Clague+Laura/17616953.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+Clague+Laura/17616953.html Tue, 17 Nov 2020 21:00:00 -0500 RTRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+REED+ELIZABETH+E/17616952.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+REED+ELIZABETH+E/17616952.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Travere+Therapeutics%2C+++++For%3A+Nov+16++Filed+by%3A+REED+ELIZABETH+E/17616952.html Tue, 17 Nov 2020 21:00:00 -0500 RTRX http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Travere+Therapeutics%2C+++++For%3A+Nov+13/17608291.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Travere+Therapeutics%2C+++++For%3A+Nov+13/17608291.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Travere+Therapeutics%2C+++++For%3A+Nov+13/17608291.html Mon, 16 Nov 2020 16:05:00 -0500 RTRX http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html for the full story. http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Mon, 16 Nov 2020 08:00:00 -0500 A.19655944 RTRX http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html for the full story. http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Mon, 16 Nov 2020 08:00:00 -0500 A.19655944 RTRX http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html for the full story. http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Mon, 16 Nov 2020 08:00:00 -0500 A.19655944 RTRX http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html for the full story. http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604331.html Mon, 16 Nov 2020 08:00:00 -0500 A.19655944 RTRX http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604167.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604167.html for the full story. http://www.streetinsider.com/Press+Releases/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604167.html Mon, 16 Nov 2020 08:00:00 -0500 RTRX http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604167.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604167.html for the full story. http://www.streetinsider.com/Globe+Newswire/Retrophin+Announces+Corporate+Name+Change+to+Travere+Therapeutics%2C+Inc./17604167.html Mon, 16 Nov 2020 08:00:00 -0500 RTRX